
Set in the mid-twenty-second century, the narrative follows Jack, a pharmaceutical pirate who reverse-engineers expensive patented drugs to manufacture cheap generics for the poor. When a performance-enhancing supplement she distributes causes lethal obsession-driven behavior in users, Jack must find a cure while evading capture. Pursuing her are Elias, a military agent, and Paladin, a newly activated combat robot. Their partnership centers on the legal and physical constraints of Paladin’s autonomy, as the machine learns to navigate gender identity and the rigid property laws that govern both artificial intelligence and indentured humans.
Readers interested in the intersection of intellectual property law and bioethics will find a detailed projection of corporate sovereignty. The story suits those who track how biotechnology and automation might reshape labor rights and individual agency. You walk away with a specific framework for understanding how legal ownership creates systemic inequality, alongside a technical look at the blurred boundaries between biological and programmed consciousness. This is for fans of hard science fiction who prefer technical accuracy over space opera tropes.
- Published
- 2017
- Language
- EN